1.

Results from the Belgian mantle cell lymphoma registry

2.

Results from the Belgian mantle cell lymphoma registry

3.

Results from the Belgian mantle cell lymphoma registry

1.

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.

2.

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.

3.

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.

1.

Primary immune thrombocytopenia in adults. Guidelines for diagnosis and treatment anno 2013 proposed by the Belgian Hematological Society

2.

Primary immune thrombocytopenia in adults. Guidelines for diagnosis and treatment anno 2013 proposed by the Belgian Hematological Society

3.

Primary immune thrombocytopenia in adults. Guidelines for diagnosis and treatment anno 2013 proposed by the Belgian Hematological Society

1.

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus

1.

Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus

1.

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

2.

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

3.

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

1.

Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (Acta Neurologica Belgica, (2018), 118, 1, (7-11),...

1.

Waldenström’s macroglobulinaemia: Belgian Hematology Society guidelines